Otero Jose Manuel
SEC CIK 2024096 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | Chief Technical Off | 136.2K | — | $98.9K | 15 | 2024-06-12 | 2026-08-18 |
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 17:00 | 2026-08-18 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | S - Sale | $4.96 | -1,304 | 136.2K | -0.9% | -$6,464 | |
| 2026-07-01 18:49 | 2026-06-29 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | A - Grant | $0.00 | +12.1K | 142.1K | +9% | $0 | |
| 2026-07-01 18:49 | 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | S - Sale | $4.48 | -4,666 | 137.5K | -3% | -$20.9K | |
| 2026-05-20 16:30 | 2026-05-18 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | S - Sale | $5.07 | -1,302 | 130.1K | -1.0% | -$6,606 | |
| 2026-03-17 | 2026-03-13 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | A - Grant | $2.64 | +5,930 | 131.4K | +5% | +$15.7K | |
| A | 2026-02-20 | 2025-11-18 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | S - Sale | $9.27 | -721 | 63.5K | -1% | -$6,684 |
| 2026-02-20 | 2026-02-18 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | S - Sale | $6.40 | -3,016 | 125.5K | -2% | -$19.3K | |
| D | 2026-02-06 | 2026-02-04 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | COO | A - Grant | $0.00 | +65.0K | 128.5K | +102% | $0 |
| 2025-11-20 | 2025-08-18 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Off | S - Sale | $9.27 | -721 | 63.5K | -1% | -$6,684 | |
| M | 2025-10-17 | 2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Off | S - Sale | $8.95 | -2,115 | 64.2K | -3% | -$18.9K |
| 2025-10-17 | 2025-10-15 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +5,940 | 66.3K | +10% | $0 | |
| 2025-08-20 | 2025-08-18 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Off | S - Sale | $4.67 | -2,848 | 60.4K | -5% | -$13.3K | |
| 2025-04-09 | 2025-03-14 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Off | A - Grant | $2.61 | +5,720 | 63.2K | +10% | +$14.9K | |
| D | 2025-01-10 | 2025-01-07 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +26.2K | 57.5K | +84% | $0 |
| DT | 2024-06-14 | 2024-06-12 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +31.2K | 31.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations